Equities researchers at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Get Free Report) in a note issued to investors on Thursday. The firm set a "hold" rating on the software maker's stock.
Veradigm Trading Down 0.6 %
MDRX stock traded down $0.05 during midday trading on Thursday, reaching $9.00. 57,649 shares of the company's stock traded hands, compared to its average volume of 1,679,889. The company has a 50-day simple moving average of $9.54 and a two-hundred day simple moving average of $9.10. Veradigm has a 1-year low of $5.01 and a 1-year high of $13.62.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Innealta Capital LLC acquired a new stake in Veradigm in the 2nd quarter valued at about $38,000. Meadow Creek Wealth Advisors LLC bought a new stake in shares of Veradigm during the first quarter worth $83,000. Vanguard Group Inc. lifted its stake in shares of Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker's stock valued at $149,754,000 after acquiring an additional 95,291 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Veradigm by 6.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker's stock valued at $16,749,000 after acquiring an additional 99,528 shares during the period. Finally, Tyro Capital Management LLC bought a new position in Veradigm in the first quarter valued at about $9,055,000.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
